Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -8.40% is 201% below its 5-year average of 8.31%, near the low end of its 5-year range (-8.40%–16.74%).
As of the fiscal period ended Saturday, June 27, 2026. 76.76% below its 12-month average of -4.75%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
-8.40%
RETURN ON EQUITY (ROE) AVG TTM
-4.75%
RETURN ON EQUITY (ROE) AVG 3Y
4.04%
RETURN ON EQUITY (ROE) AVG 5Y
8.31%
RETURN ON EQUITY (ROE) AVG 10Y
15.29%
RETURN ON EQUITY (ROE) AVG 15Y
16.24%
RETURN ON EQUITY (ROE) AVG 20Y
12.22%
CURRENT VS TTM AVG
-76.76%
CURRENT VS 3Y AVG
-307.63%
CURRENT VS 5Y AVG
-201.06%
CURRENT VS 10Y AVG
-154.92%
CURRENT VS 15Y AVG
-151.72%
CURRENT VS 20Y AVG
-168.70%
SECTOR MEDIAN · HEALTHCARE
13.25%
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
-163.38%
vs the sector median at left
Charles River Laboratories International, Inc.
Market Cap
$13.52B
Return on Equity (ROE)
-8.40%
TTM Avg
-4.75%
3Y Avg
4.04%
5Y Avg
8.31%
Market Cap
$13.20B
Return on Equity (ROE)
2.86%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
Market Cap
$14.18B
Return on Equity (ROE)
3.29%
TTM Avg
3.59%
3Y Avg
3.35%
5Y Avg
7.68%
Market Cap
$12.85B
Return on Equity (ROE)
-17.13%
TTM Avg
-12.46%
3Y Avg
-8.76%
5Y Avg
-1.37%
Market Cap
$12.58B
Return on Equity (ROE)
10.49%
TTM Avg
6.83%
3Y Avg
5.29%
5Y Avg
3.21%
Market Cap
$14.50B
Return on Equity (ROE)
46.68%
TTM Avg
29.72%
3Y Avg
22.87%
5Y Avg
17.28%
Market Cap
$11.95B
Return on Equity (ROE)
23.91%
TTM Avg
22.63%
3Y Avg
21.83%
5Y Avg
21.13%
Market Cap
$11.56B
Return on Equity (ROE)
N/A
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$15.60B
Return on Equity (ROE)
29.88%
TTM Avg
23.51%
3Y Avg
17.50%
5Y Avg
13.68%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | $13.52B | -8.40% | -4.75% | 4.04% | 8.31% |
| The Cooper Companies, Inc. (COO)vs › | $13.20B | 2.86% | 4.70% | 4.67% | 11.22% |
| Revvity, Inc. (RVTY)vs › | $14.18B | 3.29% | 3.59% | 3.35% | 7.68% |
| Baxter International Inc. (BAX)vs › | $12.85B | -17.13% | -12.46% | -8.76% | -1.37% |
| Penumbra, Inc. (PEN)vs › | $12.58B | 10.49% | 6.83% | 5.29% | 3.21% |
| Exelixis, Inc. (EXEL)vs › | $14.50B | 46.68% | 29.72% | 22.87% | 17.28% |
| Encompass Health Corporation (EHC)vs › | $11.95B | 23.91% | 22.63% | 21.83% | 21.13% |
| DaVita Inc. (DVA)vs › | $11.56B | N/A | 329.18% | 200.63% | 164.66% |
| Solventum Corporation (SOLV)vs › | $15.60B | 29.88% | 23.51% | 17.50% | 13.68% |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 8.63% | 6.23% | 8.78% | 10.01% |
ROE
-8.4%
ROA
-3.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-27 | -8.40% |
| 2026-03-28 | -6.28% |
| 2025-12-27 | -4.56% |
| 2025-09-27 | -2.45% |
| 2025-06-28 | -2.06% |
| 2025-03-29 | -0.99% |
| 2024-12-31 | 0.30% |
| 2024-09-28 | 10.92% |
| 2024-06-29 | 11.60% |
| 2024-03-30 | 12.05% |
| 2023-12-31 | 13.20% |
| 2023-09-30 | 14.37% |
| 2023-07-01 | 14.89% |
| 2023-04-01 | 15.97% |
| 2022-12-31 | 16.34% |
| 2022-09-24 | 16.61% |
| 2022-06-25 | 16.74% |
| 2022-03-26 | 16.19% |
| 2021-12-31 | 15.42% |
| 2021-09-25 | 16.34% |
| 2021-06-26 | 17.08% |
| 2021-03-27 | 17.17% |
| 2020-12-31 | 17.23% |
| 2020-09-26 | 15.89% |
| 2020-06-27 | 15.48% |
| 2020-03-28 | 14.99% |
| 2019-12-31 | 15.42% |
| 2019-09-28 | 15.10% |
| 2019-06-29 | 15.04% |
| 2019-03-30 | 16.37% |
| 2018-12-31 | 17.18% |
| 2018-09-29 | 10.92% |
| 2018-06-30 | 10.91% |
| 2018-03-31 | 11.34% |
| 2017-12-31 | 11.80% |
| 2017-09-30 | 19.37% |
| 2017-07-01 | 19.01% |
| 2017-04-01 | 18.76% |
| 2016-12-31 | 18.50% |
| 2016-09-24 | 16.36% |
| 2016-06-25 | 17.03% |
| 2016-03-26 | 19.87% |
| 2015-12-31 | 20.37% |
| 2015-09-26 | 20.53% |
| 2015-06-27 | 19.84% |
| 2015-03-28 | 18.99% |
| 2014-12-31 | 18.85% |
| 2014-09-27 | 17.70% |
| 2014-06-28 | 17.48% |
| 2014-03-29 | 15.74% |
| 2013-12-31 | 16.04% |
| 2013-09-28 | 15.56% |
| 2013-06-29 | 14.39% |
| 2013-03-30 | 15.35% |
| 2012-12-31 | 16.19% |
| 2012-09-29 | 17.73% |
| 2012-06-30 | 18.27% |
| 2012-03-31 | 18.94% |
| 2011-12-31 | 20.85% |
| 2011-09-24 | -48.23% |
| 2011-06-25 | -51.61% |
| 2011-03-26 | -57.33% |
| 2010-12-31 | -48.98% |
| 2010-09-25 | 2.35% |
| 2010-06-26 | 6.22% |
| 2010-03-27 | 7.69% |
| 2009-12-31 | 8.32% |
| 2009-09-26 | -41.88% |
| 2009-06-27 | -43.40% |
| 2009-03-28 | -44.49% |
| 2008-12-31 | -43.63% |
| 2008-09-27 | 9.02% |
| 2008-06-28 | 8.89% |
| 2008-03-29 | 8.47% |
| 2007-12-31 | 8.30% |
| 2007-09-29 | 8.47% |
| 2007-06-30 | 5.39% |
| 2007-03-31 | 4.94% |
| 2006-12-31 | -3.50% |
| 2006-09-30 | -2.61% |
| 2006-07-01 | 0.50% |
| 2006-04-01 | 0.82% |
| 2005-12-31 | 7.77% |
| 2005-09-24 | 6.25% |
| 2005-06-25 | 6.09% |
| 2005-03-26 | 6.58% |
| 2004-12-31 | 6.10% |
| 2004-09-25 | 16.40% |
| 2004-06-26 | 16.21% |
| 2004-03-27 | 15.87% |
| 2003-12-31 | 17.25% |
| 2003-09-27 | 17.83% |
| 2003-06-28 | 18.45% |
